IP Library › Granted Patent US 9,238,060
Granted Patent B2
US 9,238,060 · App. 14/176,330 · Granted Jan 19, 2016

Chimeric factor VII molecules

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,238,060
App. No.
14/176,330
Granted
Jan 19, 2016
Kind
B2
Abstract

The present invention relates to chimeric Factor VII polypeptides and methods of using the same.

Claims (6)

1. A method for treating uncontrolled bleeding in a hemophiliac or non-hemophiliac subject in need of treatment, the method comprising:

administering to the subject a chimeric coagulation protein comprising:

a GLA domain selected from the group consisting of the GLA domain of Factor IX and the GLA domain of Protein S and an EGF-1 domain of Factor IX; and

EGF-2 and catalytic domains of Factor VII.

2. The method of claim 1 , wherein the uncontrolled bleeding is associated with a congenital, acquired, or induced defect.

3. The method of claim 2 , wherein the defect has an origin selected from cellular, physiological, or molecular.